Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy:: A Post Hoc Analysis from the SONAR Trial

Simke W. Waijer; Sieta T. De Vries; Robert Busch; Di Xie; Ron T. Gansevoort; Fan Fan Hou; Jose L. Górriz; Gozewijn D. Laverman; Luca De Nicola; Julio Pascual; Michele Provenzano; Pablo E. Pergola; Sydney C.w. Tang; Christoph Wanner; Philippe Zaoui; Hans-henrik Parving; Dick De Zeeuw; Hiddo J.l. Heerspink

doi:10.1681/ASN.2021040498

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy: A Post Hoc Analysis from the SONAR Trial

Simke W. Waijer
, Sieta T. De Vries
, Robert Busch
, Di Xie
, Ron T. Gansevoort
, Fan Fan Hou
, Jose L. Górriz
, Gozewijn D. Laverman
, Luca De Nicola
, Julio Pascual
, Michele Provenzano
, Pablo E. Pergola
, Sydney C.w. Tang
, Christoph Wanner
, Philippe Zaoui
, Hans-henrik Parving
, Dick De Zeeuw
, Hiddo J.l. Heerspink^*

^*Corresponding author for this work

Biomedical Signals and Systems

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

124 Downloads (Pure)

Original language	English
Pages (from-to)	2731-2734
Number of pages	4
Journal	Journal of the American Society of Nephrology
Volume	32
Issue number	11
DOIs	https://doi.org/10.1681/ASN.2021040498
Publication status	Published - 1 Nov 2021

Keywords

22/2 OA procedure

Access to Document

10.1681/ASN.2021040498

2731.fullFinal published version, 618 KBLicence: Taverne

Cite this

Waijer, S. W., De Vries, S. T., Busch, R., Xie, D., Gansevoort, R. T., Hou, F. F., Górriz, J. L., Laverman, G. D., De Nicola, L., Pascual, J., Provenzano, M., Pergola, P. E., Tang, S. C. W., Wanner, C., Zaoui, P., Parving, H., De Zeeuw, D., & Heerspink, H. J. L. (2021). Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy: A Post Hoc Analysis from the SONAR Trial. Journal of the American Society of Nephrology, 32(11), 2731-2734. https://doi.org/10.1681/ASN.2021040498

@article{dede695d572b4972863cd7da66a5e3fe,

title = "Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan{\textquoteright}s Efficacy:: A Post Hoc Analysis from the SONAR Trial",

keywords = "22/2 OA procedure",

author = "Waijer, \{Simke W.\} and \{De Vries\}, \{Sieta T.\} and Robert Busch and Di Xie and Gansevoort, \{Ron T.\} and Hou, \{Fan Fan\} and G{\'o}rriz, \{Jose L.\} and Laverman, \{Gozewijn D.\} and \{De Nicola\}, Luca and Julio Pascual and Michele Provenzano and Pergola, \{Pablo E.\} and Tang, \{Sydney C.w.\} and Christoph Wanner and Philippe Zaoui and Hans-henrik Parving and \{De Zeeuw\}, Dick and Heerspink, \{Hiddo J.l.\}",

year = "2021",

month = nov,

day = "1",

doi = "10.1681/ASN.2021040498",

language = "English",

volume = "32",

pages = "2731--2734",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "Wolters Kluwer Health",

number = "11",

}

Waijer, SW, De Vries, ST, Busch, R, Xie, D, Gansevoort, RT, Hou, FF, Górriz, JL, Laverman, GD, De Nicola, L, Pascual, J, Provenzano, M, Pergola, PE, Tang, SCW, Wanner, C, Zaoui, P, Parving, H, De Zeeuw, D & Heerspink, HJL 2021, 'Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy: A Post Hoc Analysis from the SONAR Trial', Journal of the American Society of Nephrology, vol. 32, no. 11, pp. 2731-2734. https://doi.org/10.1681/ASN.2021040498

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy: A Post Hoc Analysis from the SONAR Trial. / Waijer, Simke W.; De Vries, Sieta T.; Busch, Robert et al.
In: Journal of the American Society of Nephrology, Vol. 32, No. 11, 01.11.2021, p. 2731-2734.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy:

T2 - A Post Hoc Analysis from the SONAR Trial

AU - Waijer, Simke W.

AU - De Vries, Sieta T.

AU - Busch, Robert

AU - Xie, Di

AU - Gansevoort, Ron T.

AU - Hou, Fan Fan

AU - Górriz, Jose L.

AU - Laverman, Gozewijn D.

AU - De Nicola, Luca

AU - Pascual, Julio

AU - Provenzano, Michele

AU - Pergola, Pablo E.

AU - Tang, Sydney C.w.

AU - Wanner, Christoph

AU - Zaoui, Philippe

AU - Parving, Hans-henrik

AU - De Zeeuw, Dick

AU - Heerspink, Hiddo J.l.

PY - 2021/11/1

Y1 - 2021/11/1

KW - 22/2 OA procedure

U2 - 10.1681/ASN.2021040498

DO - 10.1681/ASN.2021040498

M3 - Article

C2 - 34417318

SN - 1046-6673

VL - 32

SP - 2731

EP - 2734

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 11

ER -